BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 31850169)

  • 1. Systemic steroids as an aid to the management of Idiopathic Polypoidal Choroidal Vasculopathy (IPCV): A descriptive analysis.
    Sudhalkar A; Balakrishnan D; Jalali S; Narayanan R
    Saudi J Ophthalmol; 2016; 30(1):14-9. PubMed ID: 26949352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. THE INCIDENCE, CHARACTERISTICS, MANAGEMENT, PROGNOSIS, AND CLASSIFICATION OF BREAKTHROUGH VITREOUS HEMORRHAGE SECONDARY TO POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Zhao XY; Luo MY; Meng LH; Zhang WF; Li B; Wang EQ; Liu SZ; Yu WH; Chen YX
    Retina; 2021 Aug; 41(8):1675-1685. PubMed ID: 33395221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term Clinical Course after Vitrectomy for Breakthrough Vitreous Hemorrhage Secondary to Neovascular Age-related Macular Degeneration and Polypoidal Choroidal Vasculopathy.
    Kim JH; Kim JW; Kim CG; Lee DW
    Sci Rep; 2020 Jan; 10(1):359. PubMed ID: 31941971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Factors and Long-term Surgical Outcomes for Exudative Age-related Macular Degeneration with Breakthrough Vitreous Hemorrhage.
    Kim TY; Kang HG; Choi EY; Koh HJ; Kim SS; Lee JH; Kim M; Byeon SH; Lee CS
    Korean J Ophthalmol; 2020 Aug; 34(4):281-289. PubMed ID: 32783420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Polypoidal choroidal vasculopathy].
    Yuzawa M
    Nippon Ganka Gakkai Zasshi; 2012 Mar; 116(3):200-31; discussion 232. PubMed ID: 22568102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. THREE-YEAR RESULTS OF POLYPOIDAL CHOROIDAL VASCULOPATHY TREATED WITH PHOTODYNAMIC THERAPY: Retrospective Study and Systematic Review.
    Wong CW; Cheung CM; Mathur R; Li X; Chan CM; Yeo I; Wong E; Lee SY; Wong D; Wong TY
    Retina; 2015 Aug; 35(8):1577-93. PubMed ID: 25719986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term observation of vitrectomy without subretinal hemorrhage management for massive vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.
    Li ZX; Hu YJ; Atik A; Lu L; Hu J
    Int J Ophthalmol; 2019; 12(12):1859-1864. PubMed ID: 31850169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Visual outcomes of vitrectomy for polypoidal choroidal vasculopathy-related breakthrough vitreous haemorrhage.
    Lin HC; Yang CH; Yang CM;
    Eye (Lond); 2014 Jul; 28(7):797-806; quiz 807. PubMed ID: 24924445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcomes of vitrectomy for breakthrough vitreous hemorrhage in eyes with exudative age-related macular degeneration.
    Iwase T; Baba T; Saito Y; Nizawa T; Yokouchi H; Kubota-Taniai M; Kitahashi M; Yamamoto S
    Int Ophthalmol; 2021 May; 41(5):1835-1844. PubMed ID: 33611763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vitreous haemorrhage in massive hemorrhagic polypoidal choroidal vasculopathy: clinical characteristics and surgical outcomes: Vitreous hemorrhage in PCV.
    Narayanan R; Mithal K; Jalali S; Chhablani JK; Mathai A; Ali MH
    Int J Retina Vitreous; 2015; 1():25. PubMed ID: 27847618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical features and outcomes of breakthrough vitreous hemorrhage secondary to polypoidal choroidal vasculopathy.
    Li MS; Tsen CL
    PLoS One; 2022; 17(12):e0279778. PubMed ID: 36584198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 23-Gauge vitrectomy with external drainage therapy as a novel procedure to displace massive submacular hemorrhage secondary to polypoidal choroidal vasculopathy.
    Liu H; Zhang LY; Li XX; Wu MQ
    Medicine (Baltimore); 2016 Aug; 95(32):e4192. PubMed ID: 27512837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of iOCT in Vitreoretinal Surgery for Dense Vitreous Hemorrhage in a Chinese Population.
    Tao J; Wu H; Chen Y; Mao J; Cheng D; Lin J; Shen L
    Curr Eye Res; 2019 Feb; 44(2):219-224. PubMed ID: 30299988
    [TBL] [Abstract][Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.